BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  Seattle Genetics Reports Third Quarter 2016 Financial Results

  October 28, 2016

   · 

  1 min read
• Business

  McKesson Reports Fiscal 2017 Second-Quarter Results And Revised Fiscal 2017 Outlook

  October 28, 2016

   · 

  1 min read
• Business

  PURE Bioscience Reports Fiscal 2016 Year-End Financial Results

  October 28, 2016

   · 

  1 min read
• Business

  Takeda Reports First Half FY2016 Results And Raises Full Year Profit Guidance

  October 28, 2016

   · 

  1 min read
• Deals

  IDT Australia Limited Divests CMAX Clinical Trial Business To I’rom Group Co. Ltd

  October 28, 2016

   · 

  4 min read
• Genetown

  Biogen’s Regulatory Applications For Nusinersen As A Treatment For Spinal Muscular Atrophy Accepted By FDA And EMA

  October 28, 2016

   · 

  8 min read
• Drug Development

  Opexa Therapeutics’ Stock Slammed After MS Candidate Flunks Phase II Test

  October 28, 2016

   · 

  4 min read
• FDA

  Swedish Orphan Biovitrum: Alprolix Approved In Switzerland For The Treatment Of Hemophilia B

  October 28, 2016

   · 

  4 min read
• Prometheus BioScience Inc. Raises EUR 10 Million In A Series C-extension Financing To Advance Its Broad Product Pipeline In Liver Diseases

  October 28, 2016

   · 

  4 min read
• BioForest

  Adaptive Biotech Announces The Inclusion Of NGS-Based MRD Assessment In The NCCN Clinical Practice Guidelines For Multiple Myeloma

  October 28, 2016

   · 

  3 min read